16 analysts have shared their evaluations of Comerica CMA during the recent three months, expressing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 6 | 6 | 1 | 1 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 3 | 2 | 0 | 0 |
| 2M Ago | 0 | 0 | 2 | 1 | 1 |
| 3M Ago | 2 | 2 | 2 | 0 | 0 |
Analysts have set 12-month price targets for Comerica, revealing an average target of $74.44, a high estimate of $85.00, and a low estimate of $64.00. This current average has increased by 4.2% from the previous average price target of $71.44.
Interpreting Analyst Ratings: A Closer Look
The standing of Comerica among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| David George | Baird | Raises | Outperform | $80.00 | $75.00 |
| Manan Gosalia | Morgan Stanley | Lowers | Equal-Weight | $71.00 | $76.00 |
| Karl Shepard | RBC Capital | Lowers | Outperform | $76.00 | $78.00 |
| Peter Winter | DA Davidson | Lowers | Neutral | $67.00 | $71.00 |
| Christopher Mcgratty | Keefe, Bruyette & Woods | Lowers | Outperform | $77.00 | $82.00 |
| David George | Baird | Lowers | Outperform | $75.00 | $80.00 |
| Ryan Nash | Goldman Sachs | Lowers | Neutral | $71.00 | $85.00 |
| Anthony Elian | JP Morgan | Lowers | Neutral | $70.00 | $73.00 |
| Jason Goldberg | Barclays | Raises | Underweight | $68.00 | $66.00 |
| Nicholas Holowko | UBS | Raises | Sell | $64.00 | $60.00 |
| David Rochester | Compass Point | Raises | Buy | $80.00 | $64.00 |
| Christopher Mcgratty | Keefe, Bruyette & Woods | Raises | Outperform | $82.00 | $72.00 |
| Scott Siefers | Piper Sandler | Raises | Neutral | $72.00 | $64.00 |
| Ryan Nash | Goldman Sachs | Raises | Buy | $85.00 | $71.00 |
| David George | Baird | Raises | Outperform | $80.00 | $75.00 |
| Mike Mayo | Wells Fargo | Raises | Equal-Weight | $73.00 | $51.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Comerica. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Comerica compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Comerica's stock. This comparison reveals trends in analysts' expectations over time.
Capture valuable insights into Comerica's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Comerica analyst ratings.
Delving into Comerica's Background
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.
Unraveling the Financial Story of Comerica
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Comerica's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 1.11%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Comerica's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 19.88%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Comerica's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.48%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Comerica's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.21%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Comerica's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.09.
What Are Analyst Ratings?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
